Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 266 Lung Neoplasms 102 Adenocarcinoma of Lung 28 Mesothelioma, Malignant 24 Mesothelioma 22 Neoplasms 18 Meningeal Carcinomatosis 18 Brain Neoplasms 16 Head and Neck Neoplasms 14 Neoplasm Metastasis 13 Ovarian Neoplasms 9 NSCLC 9 Colorectal Neoplasms 8 Adenocarcinoma, Bronchiolo-Alveolar 8 Breast Neoplasms 7 Recurrence 6 Carcinoma, Transitional Cell 6 Squamous Cell Carcinoma of Head and Neck 5 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Lymphoma 5 Esophageal Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Sarcoma 4 Non-squamous Non-small Cell Lung Cancer 4 Non-small Cell Lung Cancer Metastatic 4 Fallopian Tube Neoplasms 4 Adenocarcinoma 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3

Interventions

pembrolizumab 1 osimertinib 1 binimetinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Non-small Cell Carcinoma × Pemetrexed × Clear all

NCT04695925 2025-10-15

TOP

Sun Yat-sen University

Phase 3 Active not recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡